SCHEMBL8774927

SCHEMBL8774927

COc1ccc(F)c(-c2nc(Cl)c([N+](=O)[O-])c(Cl)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
IDH2 P48735 1/20 0.44
AMY1A P0DUB6 2/20 0.41
MERTK Q12866 1/20 0.39
S1PR4 O95977 1/20 0.38
HNF4A P41235 2/20 0.38
MAPK1 P28482 2/20 0.38
DCTPP1 Q9H773 2/20 0.38
LMNA P02545 1/20 0.38
RAF1 P04049 1/20 0.38
HPGD P15428 1/20 0.38
GFER P55789 1/20 0.38
PAX8 Q06710 1/20 0.38
GRK6 P43250 1/20 0.37
PTGES O14684 1/20 0.37
PIN1 Q13526 1/20 0.37
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8774775 0.84 IDH2 (0.44) ALDH1A1MAPTKDM4EIDH2AMY1A
SCHEMBL7350863 0.84 HSP90AA1 (0.42) ALDH1A1MAPTKDM4EAMY1AMERTK
SCHEMBL8845427 0.83 IDH2 (0.41) ALDH1A1MAPTKDM4EIDH2AMY1A
SCHEMBL8774771 0.81 IDH2 (0.39) ALDH1A1MAPTKDM4EIDH2AMY1A
SCHEMBL23004696 0.74 KMT2A (0.39) ALDH1A1MAPTKDM4EAMY1AMAPK1
SCHEMBL7357357 0.72 PTGES (0.38) ALDH1A1MAPTKDM4EIDH2AMY1A
SCHEMBL8774866 0.71 IDH2 (0.51) ALDH1A1MAPTIDH2AMY1AGRK6
SCHEMBL25680030 0.69 ATM (0.41) ALDH1A1MAPTS1PR4LMNARAB9A
SCHEMBL6520 0.69 TDP1 (0.58) ALDH1A1MAPTKDM4EAMY1AMERTK
SCHEMBL29744326 0.69 ALDH1A1 (0.56) ALDH1A1MAPTKDM4EMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688654-A GAMMA-AMINOBUTYRIC ACID NEUROGEN CORPORATION (US) 1997-11-18 US disclosed
EP-0639275-B1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORP (US) 1997-09-17 EP disclosed
US-5597920-A Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes NEUROGEN CORPORATION (US) 1997-01-28 US disclosed
EP-0639275-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES. NEUROGEN CORP (US) 1995-02-22 EP disclosed
WO-1993022681-A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES NEUROGEN CORPORATION (US) 1993-11-11 WO disclosed